RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury
Stock Information for RespireRx Pharmaceuticals Inc
Loading
Please wait while we load your information from QuoteMedia.